Status:
WITHDRAWN
Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19
Lead Sponsor:
NYU Langone Health
Conditions:
COVID-19
Eligibility:
All Genders
18-79 years
Phase:
PHASE2
Brief Summary
For this study, 48 patients who have been diagnosed with COVID-19 will be randomly assigned to four study groups: control, saline, chlorhexidine gluconate, and povidone-iodine. Each patient will be as...
Detailed Description
COVID-19 has emerged as a worldwide pandemic and there is a strong need for identification of any measures that can be used to treat this illness or reduce its transmission from person to person. Povi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Positive test for COVID-19
- Age 18-79 years
- Willing and able to perform oral gargles and nasal rinses four times daily
- Exclusion Criteria
- Requiring mechanical ventilation
- Unable or unwilling to perform oral gargles and nasal rinses four times daily
- History of chronic upper respiratory tract disease
- Known iodine allergy
- History of thyroid disease
Exclusion
Key Trial Info
Start Date :
April 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 9 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04344236
Start Date
April 9 2020
End Date
May 9 2020
Last Update
May 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016